Bupivacaine vs Oxybuprocaine Topical Anesthesia in IVI

• Status: Recruiting
• Trial end date: 2021-12-01
• Target enrollment: 0
• Participant gender: All

Summary

comparing two local anaesthetic agents, Bupivacaine 0.5% versus Oxybuprocaine used topically to provide surface anaesthesia before IVI procedures.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Research Institute of Ophthalmology, Egypt
• Treatments: Bupivacaine

Criteria

Inclusion Criteria:

• All patients between 30 to 70 years

Exclusion Criteria:

• uncooperative patients